Neuroscience

Study identifies new concepts for GLP-1 action in the brain

Researcher Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named the 2023 breakthrough of the year by the Science Magazine. Not only have millions of people ...

Medical research

Study finds serotonin reduction causes long COVID symptoms

Patients with long COVID—the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19—can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according ...

page 4 from 40